LOS & Vaccine

Descripción

(Meningitis) Medical Microbiology Fichas sobre LOS & Vaccine, creado por gina_evans0312 el 25/04/2014.
gina_evans0312
Fichas por gina_evans0312, actualizado hace más de 1 año
gina_evans0312
Creado por gina_evans0312 hace alrededor de 10 años
193
0

Resumen del Recurso

Pregunta Respuesta
LOS Lipo-Oligosaccharides
LOS Release Usually during cell death, but can be released in vesicles
LOS & TLR4 LOS stimulates TLR4 on macrophage surface leading to the release of cytokines
LOS & Shock Release of cytokines by TLR4 leads to shock like symptoms in the body
LOS & Rash Release of cytokines uses up compliment factors leading to bleeding under the skin and distinctive rash
Vaccine- Components Capsular polysaccharides on a carrier protein
Vaccine- Use Igs and memory cells are produced against capsular proteins, conveying protection and reducing colonisation, preventing spread to others
Vaccine- Response Time A few weeks
Vaccine- Variations Stains vary (6 of 13 causes menin.) so vaccine focuses on Men. C
Vaccine- Men. B Common in Europe but no vaccine
Mostrar resumen completo Ocultar resumen completo

Similar

Meningitis Infection
gina_evans0312
Neissaria Family
gina_evans0312
Online Gram Stain Module
mattpalmer789
Culture Media
gina_evans0312
Lecture One Week One - Introduction
Maddie McIntyre
Lecture Two Week One - Introduction (2)
Maddie McIntyre
CNS Infections
Matthew Coulson
Conjugation
gina_evans0312
Super-Antigens & Toxins
gina_evans0312
E. Coli as a UTI
gina_evans0312
Gastrointestinal Infections: Toxins
hands97